Vyant Bio Inc (VYNT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-MEDICAL LABORATORIES

2370 STATE ROUTE 70 WEST CHERRY HILL,, NJ 08002

Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.

Data as of 2021-10-09 10:00:03 -0400
Market Cap68.117 Million Shares Outstanding28.986 Million Avg 30-day Volume69.646 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.8708 52-week High/Low17.5 / 2.11 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from VYNT instead.

View recent insider trading info

Funds Holding VYNT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VYNT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

41.4 Thousand total shares from 5 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BOEHM MARCUS

  • Director
118,786 2021-09-29 8

YEH YUNG-PING CHIEF INNOVATION OFFICER

  • Officer
  • Director
1,327,625 2021-08-25 5

ROBERTS JOHN A CHIEF EXECUTIVE OFFICER

  • Officer
34,807 2021-08-23 4

HANSEN PAUL R.

  • Director
682,858 2021-08-19 4

FLETCHER R JOHN

  • Director
38,976 2021-05-21 3

LAFRENCE ANDREW D.C. CHIEF FINANCIAL OFFICER

  • Officer
59,202 2021-05-20 4

HOROBIN JOANNA

  • Director
18,083 2021-03-30 2

HARRIS GEOFFREY E.

  • Director
13,015 2021-03-30 1

MCLEOD HOWARD

  • Director
13,015 2021-03-30 1

BRANDT RALF PRESIDENT, DISCOVERY SERVICES

  • Officer
100,000 2021-03-30 1

MILES MICHAEL GLENN CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-02 0

PRENDERGAST FRANKLYN G

  • Director
0 2019-07-23 0

CHAGANTI RAJU S.K.

  • Director
0 2019-07-23 0

CANNON EDMUND

  • Director
0 2019-07-23 0

PAPPAJOHN JOHN

  • Director
4,781,204 2019-01-31 0

FINGER WILLIAM LANSING EVP PRECISION MEDICINE

  • Officer
0 2019-01-04 0

MCCARTNEY MICHAEL BRIAN CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-08-15 0

SHAKNOVICH RITA CHIEF MEDICAL OFFICER

  • Officer
0 2018-05-10 0

WIDMANN THOMAS F

  • Director
0 2017-11-21 0

WELSH MICHAEL J.

  • Director
12,540 2017-09-28 0

GITELMAN IGOR CHIEF ACCOUNTING OFFICER

  • Officer
937 2017-05-23 0

SHARMA PANNA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2017-02-22 0

SITAR EDWARD J CHIEF FINANCIAL OFFICER

  • Officer
14,167 2016-11-16 0

HEPBURN STEVEN

  • FORMER OFFICER
No longer subject to file 2015-10-19 0

EL NAGGAR JANE HOULDSWORTH VP OF RESEARCH AND DEVELOPMENT

  • Officer
0 2014-12-11 0

BROWNLIE KEITH L

  • Director
0 2014-05-22 0

ROTHMAN PAUL

  • Director
5,000 2014-05-22 0

PECORA ANDREW L

  • Director
2,391 2013-11-18 0

THOMPSON TOMMY G

  • Director
2,500 2013-10-10 0

CZEREPAK ELIZABETH CHIEF FINANCIAL OFFICER

  • Officer
0 2013-04-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BOEHM MARCUS - Director by trust

2021-09-30 08:45:20 -0400 2021-09-29 P 5,000 $2.44 a 118,786 indirect yes 0.8584 -1.7167 0.8584 2 -5.5794 3

BOEHM MARCUS - Director by trust

2021-08-26 08:45:25 -0400 2021-08-25 P 5,000 $2.58 a 113,786 indirect yes 1.1236 2.9963 -11.985 3.3708 5 -17.603 27

YEH YUNG-PING - Director - Officer CHIEF INNOVATION OFFICER

2021-08-27 08:45:24 -0400 2021-08-25 P 1,000 $2.64 a 12,262 direct -2.963 -1.8519 -14.4444 2.2222 4 -18.5185 26

ROBERTS JOHN A - Officer CHIEF EXECUTIVE OFFICER

2021-08-25 17:03:47 -0400 2021-08-23 P 10,406 $2.41 a 34,807 direct 1.1236 2.9963 -11.985 3.3708 5 -17.603 27

HANSEN PAUL R. - Director

2021-08-23 15:42:45 -0400 2021-08-19 P 20,000 $2.35 a 617,957 direct -2.3077 1.1538 -11.5385 6.1538 7 -15.3846 29

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VYANT BIO INC VYNT 2021-10-15 22:15:04 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 21:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 21:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 20:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 20:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 19:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 19:15:04 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 18:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 18:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 17:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 17:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 16:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 16:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 15:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 15:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 14:45:02 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 14:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 13:45:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 13:15:03 UTC -13.0281 13.0981 750000
VYANT BIO INC VYNT 2021-10-15 12:45:03 UTC -13.0281 13.0981 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VYNT -300.0 shares, $-1122.0 2021-06-30 N-PORT

Elevate your investments